Comparative evaluation of serum thyroxine, free thyroxine and thyrotropin determinations in screening of thyroid function.

Annals of clinical research Pub Date : 1988-01-01
P Nuutila, K Irjala, J Viikari, V P Prinssi, H L Kaihola
{"title":"Comparative evaluation of serum thyroxine, free thyroxine and thyrotropin determinations in screening of thyroid function.","authors":"P Nuutila,&nbsp;K Irjala,&nbsp;J Viikari,&nbsp;V P Prinssi,&nbsp;H L Kaihola","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>We assessed a highly sensitive immunoradiometric thyrotropin (TSH) assay in screening thyroid dysfunction in 130 consecutive outpatients from a department of medicine and 224 patients from a municipal health centre. In addition to clinical examination, three routine tests were done: a thyroxine radioimmunoassay, an analogue-based free thyroxine assay and an immunoradiometric TSH assay. Triiodothyronine and the TRH test were done, if the findings were discrepant. Discrepancy existed in 24% of cases. The TSH assay had no false negative results (sensitivity 100%). Therefore TSH could screen all patients with thyroid dysfunction. Free thyroxine was the most specific assay (specificity 96%), but many subclinically or overtly hypothyroid patients would have been missed, if that assay had been used alone. We conclude that TSH(IRMA) is the best first-line measurement for thyroid dysfunction testing among outpatients. An abnormal TSH result alone is not diagnostic, but should be followed by the measurement of thyroxine or free thyroxine.</p>","PeriodicalId":8084,"journal":{"name":"Annals of clinical research","volume":"20 3","pages":"158-63"},"PeriodicalIF":0.0000,"publicationDate":"1988-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of clinical research","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We assessed a highly sensitive immunoradiometric thyrotropin (TSH) assay in screening thyroid dysfunction in 130 consecutive outpatients from a department of medicine and 224 patients from a municipal health centre. In addition to clinical examination, three routine tests were done: a thyroxine radioimmunoassay, an analogue-based free thyroxine assay and an immunoradiometric TSH assay. Triiodothyronine and the TRH test were done, if the findings were discrepant. Discrepancy existed in 24% of cases. The TSH assay had no false negative results (sensitivity 100%). Therefore TSH could screen all patients with thyroid dysfunction. Free thyroxine was the most specific assay (specificity 96%), but many subclinically or overtly hypothyroid patients would have been missed, if that assay had been used alone. We conclude that TSH(IRMA) is the best first-line measurement for thyroid dysfunction testing among outpatients. An abnormal TSH result alone is not diagnostic, but should be followed by the measurement of thyroxine or free thyroxine.

血清甲状腺素、游离甲状腺素和促甲状腺素测定在甲状腺功能筛查中的比较评价。
我们评估了一种高度敏感的免疫放射促甲状腺素(TSH)测定在筛查甲状腺功能障碍中的作用,该检测包括来自内科的130名连续门诊患者和来自市卫生中心的224名患者。除临床检查外,还进行了三项常规检查:甲状腺素放射免疫测定、基于类似物的游离甲状腺素测定和免疫放射TSH测定。如果结果不一致,则进行三碘甲状腺原氨酸和TRH试验。24%的病例存在差异。TSH试验无假阴性结果(灵敏度100%)。因此TSH可筛查所有甲状腺功能障碍患者。游离甲状腺素是最特异性的检测方法(特异性96%),但如果单独使用该检测方法,许多亚临床或明显甲状腺功能减退的患者可能会被遗漏。我们认为TSH(IRMA)是门诊患者甲状腺功能障碍检测的最佳一线指标。单独的异常TSH结果不能诊断,但应随后测量甲状腺素或游离甲状腺素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信